Literature DB >> 18540925

A case series of the use of the ProSeal laryngeal mask airway in emergency lower abdominal surgery.

J Fabregat-López1, B Garcia-Rojo, T M Cook.   

Abstract

The ProSeal laryngeal mask airway (PLMA) has been used routinely for anaesthesia and for difficult airway management including airway rescue in non-fasted patients. Compared with the classic laryngeal mask airway the PLMA increases protection against gastric inflation and pulmonary aspiration, by separating the respiratory and gastro-intestinal tracts. The PLMA has potential advantages over use of the tracheal tube including smoother recovery, reduced pharyngolaryngeal morbidity and even reduced postoperative pain. We report a series of patients scheduled for emergency appendicectomy, without other risk factors for regurgitation, managed with the PLMA. Anaesthesia was induced and maintained with remifentanil, target controlled propofol and rocuronium. A series of 102 cases were managed without complications and high rates of first time placement of the PLMA (inserted over a suction tube placed in the oesophagus). With careful patient selection the PLMA may offer an alternative airway for use by experienced anaesthetists in patients undergoing minor lower abdominal surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18540925     DOI: 10.1111/j.1365-2044.2008.05539.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  2 in total

1.  Effect of Paralysis at the Time of ProSeal Laryngeal Mask Airway Insertion on Pharyngolaryngeal Morbidities. A Randomized Trial.

Authors:  Hyo-Seok Na; Young-Tae Jeon; Hyun-Jung Shin; Ah-Young Oh; Hee-Pyoung Park; Jung-Won Hwang
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

2.  General Anesthesia with the Use of SUPREME Laryngeal Mask Airway for Emergency Cesarean delivery: A Retrospective Analysis of 1039 Parturients.

Authors:  Xiaobin Fang; Quansheng Xiao; Qianling Xie; Ren Liao; Tao Zhu; Shiyang Li; Zhenyan Bo
Journal:  Sci Rep       Date:  2018-08-30       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.